The present relates to pharmaceutical compositions for oral use and production processes of the same.Particularly, conaplicacion compositions in therapy / prevention of cardiovascular diseases and / or his / su00edntomascomo Signals, for example, pu00e9ctoris angina,Myocardial infarction or Cardiac Vascular Diseases, cerebral or Peripheral.More specifically, The Invention relates to a combined formulations of u00e1cidoacetilsalicu00edlico - effective agenteantiinflamator Io, Analgesic and anti pyretic,Widely used for the treatment of rheumatoid arthritis and oosteoartritis - 5 - mononitrate isossorbida,In which 5 - mononitrate isossorbida is conveyed in ways multiparticuladas Deliberation and ACETYLSALICYLIC elu00e1cido Program gives multiparticulada conveyed in the form similar to the 5 - mononitratOr isossorbida or normal Release formulation, separately, in form or in the form of cristalesrevestidos.
展开▼
机译:本发明涉及用于口服的药物组合物及其生产方法。特别地,用于治疗/预防心血管疾病和/或他的/或sededomascomo信号,例如,p / u9ctoris心绞痛,心肌梗塞的conaplicacion组合物。更具体地讲,本发明涉及一种联合制剂,该联合制剂是有效的药物抗炎药,镇痛和退热药,广泛用于治疗类风湿性关节炎和骨关节炎-5-单硝酸盐等渗物。其中5-mononitrate isossorbida以多颗粒商议的方式进行运输,ACETYLSALICYLIC el u00e1cido计划以类似于5-mononitratOr isossorbida或正常释放制剂的形式分别以cristalesrevestidos形式或形式提供多颗粒运输。
展开▼